{
    "nctId": "NCT04481802",
    "briefTitle": "The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients",
    "officialTitle": "The Effect of RadiaAce Gel Versus Biafine in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Radiation Dermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Skin assessment (RD grade)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patients\n2. Age \\> 18\n3. Patients with histologically-confirmed diagnosis of breast cancer\n4. Patients after breast lumpectomy and that scheduled to receive radiotherapy\n5. Patients to receive minimum of 40.05 Gy to primary field\n6. Must be able to comply with treatment schedule\n7. Study-specific signed informed consent prior to randomization\n\nExclusion Criteria:\n\n1. Inflammatory or connective tissue disorders of the skin\n2. Mental incompetence, including psychological or addictive disorders which would preclude completion of questionnaires\n3. Previous radiation therapy to the breast\n4. Tumour involvement of the skin\n5. Rash, ulceration or open wound in treatment field\n6. Known skin allergy or sensitivity to Aloe Vera or Biafine\n7. Current lactation\n8. Pregnancy\n9. Any other reason that, in the opinion of the investigator, prevents the subject from",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}